Pro Share Advisors LLC Beam Therapeutics Inc. Transaction History

Pro Share Advisors LLC

$36.5 Billion
Q2 2024

A detailed history of Pro Share Advisors LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 15,072 shares of BEAM stock, worth $352,684. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,072

Previous 19,511 22.75%

Holding current value

$352,684

Previous $644,000 45.19%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$21.22 - $32.66 $94,195 - $144,977	-4,439 Reduced 22.75%	15,072 $353,000
Q1 2024 May 08, 2024	BUY	$23.46 - $45.07 $43,940 - $84,416	1,873 Added 10.62%	19,511 $644,000
Q4 2023 Feb 14, 2024	BUY	$17.69 - $30.76 $60,128 - $104,553	3,399 Added 23.87%	17,638 $480,000
Q3 2023 Nov 13, 2023	BUY	$23.01 - $32.46 $9,641 - $13,600	419 Added 3.03%	14,239 $342,000
Q2 2023 Aug 10, 2023	BUY	$29.32 - $35.99 $25,801 - $31,671	880 Added 6.8%	13,820 $441,000
Q1 2023 May 11, 2023	SELL	$30.15 - $48.79 $59,124 - $95,677	-1,961 Reduced 13.16%	12,940 $396,000
Q4 2022 Feb 02, 2023	BUY	$36.73 - $51.6 $38,052 - $53,457	1,036 Added 7.47%	14,901 $582,000
Q3 2022 Nov 04, 2022	BUY	$39.79 - $70.31 $19,656 - $34,733	494 Added 3.69%	13,865 $661,000
Q2 2022 Aug 01, 2022	SELL	$29.86 - $62.36 $130,667 - $272,887	-4,376 Reduced 24.66%	13,371 $516,000
Q1 2022 May 10, 2022	SELL	$53.73 - $82.16 $223,301 - $341,456	-4,156 Reduced 18.97%	17,747 $1.02 Million
Q4 2021 Feb 08, 2022	BUY	$68.02 - $99.06 $20,678 - $30,114	304 Added 1.41%	21,903 $1.75 Million
Q3 2021 Nov 12, 2021	SELL	$84.37 - $133.6 $154,734 - $245,022	-1,834 Reduced 7.83%	21,599 $1.88 Million
Q2 2021 Aug 13, 2021	BUY	$64.12 - $128.71 $303,031 - $608,283	4,726 Added 25.26%	23,433 $3.02 Million
Q1 2021 May 14, 2021	BUY	$71.28 - $120.75 $65,577 - $111,090	920 Added 5.17%	18,707 $1.5 Million
Q4 2020 Feb 09, 2021	BUY	$22.24 - $95.63 $395,582 - $1.7 Million	17,787 New	17,787 $1.45 Million

Others Institutions Holding BEAM

# of Institutions

230

Shares Held

73.6M

Call Options Held

283K

Put Options Held

233K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.65B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Beam Therapeutics Inc. Transaction History